Q4 2023 Chromadex Corp Earnings Call

In This Article:

Participants

Kendall Knysch; Director, Media Relations; Chromadex Corp.

Robert Fried; CEO; Chromadex Corp.

Brianna Gerber; CFO; Chromadex Corp.

Jeffrey Cohen; Analyst; Laderburg Thalmann & Co. Inc.

Mitch Pinheiro; Analyst; Sturdivant & Co., Inc.

Sean McGowan; Analyst; ROTH Capital Partners, LLC

Matt Dhane; Analyst; Tieton Capital Management, LLC

Presentation

Operator

Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corporation's Fourth Quarter 2023 earnings conference call. My name is Mandy, and I will be the conference operator today at this time, all participants are in a listen only mode. And as a reminder, this conference call is being recorded.
This afternoon, ChromaDex issued a news release announcing the Company's financial results for the fourth quarter of 2023. If you have not reviewed this information, both are available within the Investor Relations section of ChromaDex's website at www.chromadex.com.
I would now like to turn the conference call over to Kendall Canice, Head of Public Relations and partnerships. Please go ahead, Miss Kinetin.

Kendall Knysch

Thank you and good afternoon. And welcome to ChromaDex Corporation's Fourth Quarter 2023 Results Investor Call. With us today are ChromaDex's Chief Executive Officer, Rob Freeman, Chief Financial Officer, Brianna Gerber, and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join the call for Q&A.
Today's conference call may include forward-looking statements, including statements related to ChromaDex's research and development and clinical trial plans and the timing and results of such trials, the timing of future regulatory filings, the expansion of the sale of two nitrogen and new market business development opportunities, future financial results, cash needs, operating performance, investor interest and business prospects and opportunities as well as anticipated results of operations. Forward looking statements represent only the company's estimates on the date of this conference call and are not intended to give any assurance to actual future results because forward-looking statements relate to matters that have not yet occurred. These statements are inherently subject to risks and uncertainties. Many factors could cause ChromaDex's actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These risk factors include those contained in ChromaDex's annual report on Form 10-K most recently filed with the SEC, including results of operation, financial condition, cash flows as well as global market and economic conditions on our business. Please note that ChromaDex assumes no obligation to update any forward-looking statements after the date of this conference call to conform with the forward-looking statements to actual results, but the changes in its expectation In addition, certain of the financial information presented in this call references non GAAP financial measures company's earnings presentation and earnings press release, which were issued this afternoon and are available on the company's website present reconciliations to appropriate GAAP measures.
Finally, the conference call is being recorded via webcast. The webcast will be available at the Investor Relations section of our website at www.chromadex.com.
With that, it is now my pleasure to turn the call over to our Chief Executive Officer, Robert Reed.